From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
a. Involvement n (%) | Unilateral | 6 (10.71%) |
Bilateral | 25 (44.64%) | |
b. Location, n (%) | lower lobes only | 5 (8.92%) |
lower lobes plus other lobes | 23 (41.07%) | |
other than lower lobes | 3 (5.35%) | |
c. Pleural involvement, n (%) | Yes | 4 (7.14%) |
No | 52 (92.85%) | |
d. Sizes, n (%) | < 1 cm | 10 (17.85%) |
1–3 cm | 16 (28.5%) | |
> 3 cm | 5 (8.92%) | |
e. Morphology | Solid | 30(53.5%) |
Ground glass | 1(1.79%) | |
e. FDG avidity, n (%) | Positive | 4 (7.14%) |
Negative | 14 (25.0%) | |
Both FDG-positive and FDG-negative | 13 (23.21%) | |
f. SUV (gm/ml) | 5.56 ± 3.94 | |
h. Pattern of presence lung nodules, n (%) | Pulmonary nodules only | 8 (14.28%) |
Pulmonary nodules with regional lymph nodes only | 5 (8.92%) | |
Pulmonary nodules with distant metastatic lymph nodes with or without regional metastatic lymph nodes | 10 (17.85%) | |
Pulmonary nodules with lymphnodal and other distant metastases | 7 (12.50%) | |
Pulmonary nodules with distant metastases without nodal involvement | 1 (1.7%) |